As of today (2024-04-18), Teva Pharmaceutical Industries's share price is $13.18.
Teva Pharmaceutical Industries's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.75. Hence, Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow Ratio for today is 17.50.
The historical rank and industry rank for Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow or its related term are showing as below:
TEVA'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 5.76 Med: 12.91 Max: 108.84
Current: 17.61
During the past 13 years, Teva Pharmaceutical Industries's highest Price-to-Free-Cash-Flow Ratio was 108.84. The lowest was 5.76. And the median was 12.91.
TEVA's Price-to-Free-Cash-Flow is ranked better than 58.06% of 496
companies
in the Drug Manufacturers industry
Industry Median: 20.86
vs TEVA: 17.61
Teva Pharmaceutical Industries's Free Cash Flow per Share for the
three
months ended in Dec. 2023 was $0.95.
Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.75.
During the past 12 months, the average Free Cash Flow per Share Growth Rate of Teva Pharmaceutical Industries was -19.80% per year.
During the past 3 years, the average Free Cash Flow per Share Growth Rate was 8.90% per year.
During the past 5 years, the average Free Cash Flow per Share Growth Rate was -1.90% per year.
During the past 10 years, the average Free Cash Flow per Share Growth Rate was -22.30% per year.
During the past 13 years, Teva Pharmaceutical Industries's highest 3-Year average Free Cash Flow per Share Growth Rate was 91.70% per year. The lowest was -139.90% per year. And the median was 10.30% per year.
Teva Pharmaceutical Industries Price-to-Free-Cash-Flow Historical Data
The historical data trend for Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Teva Pharmaceutical Industries Annual Data
Trend
Dec14
Dec15
Dec16
Dec17
Dec18
Dec19
Dec20
Dec21
Dec22
Dec23
Price-to-Free-Cash-Flow
44.54
13.96
33.65
9.35
13.49
Teva Pharmaceutical Industries Quarterly Data
Mar19
Jun19
Sep19
Dec19
Mar20
Jun20
Sep20
Dec20
Mar21
Jun21
Sep21
Dec21
Mar22
Jun22
Sep22
Dec22
Mar23
Jun23
Sep23
Dec23
Price-to-Free-Cash-Flow
9.35
9.85
7.08
18.76
13.49
Competitive Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Teva Pharmaceutical Industries Price-to-Free-Cash-Flow Distribution
For the Drug Manufacturers industry and Healthcare sector, Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow falls into.
Teva Pharmaceutical Industries's Share Price of today is $13.18.
Teva Pharmaceutical Industries's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.75.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.
In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.
Be Aware
In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.
Teva Pharmaceutical Industries Price-to-Free-Cash-Flow Related Terms
Thank you for viewing the detailed overview of Teva Pharmaceutical Industries's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.
Teva Pharmaceutical Industries (Teva Pharmaceutical Industries) Business Description
Teva Pharmaceutical, based in Israel, is the leading generic drug manufacturer in the world. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the U.S. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in three main therapeutic areas: central nervous system with Copaxone, Ajovy and Austedo; respiratory with Qvar and ProAir; and oncology with Truxima, Herzuma, and Bendeka/Treanda. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a U.S.-based generic and specialty drug distributor.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TEVA has been successfully added to your 